PetIQ (PETQ)
(Delayed Data from NSDQ)
$16.53 USD
+0.21 (1.29%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $16.51 -0.02 (-0.12%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth F Momentum A VGM
PetIQ (PETQ) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$29.00 | $30.00 | $28.00 | 77.70% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for PetIQ comes to $29.00. The forecasts range from a low of $28.00 to a high of $30.00. The average price target represents an increase of 77.7% from the last closing price of $16.32.
Analyst Price Targets (4 )
Broker Rating
PetIQ currently has an average brokerage recommendation (ABR) of 1.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 1.33 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, five are Strong Buy, representing 83.33% of all recommendations. A month ago, Strong Buy represented 83.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
2/29/2024 | Lake Street Capital Markets | Ryan R Meyers | Strong Buy | Strong Buy |
2/29/2024 | Truist Securities | William B Chappell | Strong Buy | Strong Buy |
2/29/2024 | The Benchmark Company | John Lawrence | Strong Buy | Strong Buy |
11/7/2023 | William Blair | Jon R Andersen | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.33 |
ABR (Last week) | 1.33 |
# of Recs in ABR | 6 |
Average Target Price | $29.00 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 142 of 252 |
Current Quarter EPS Est: | 0.42 |